Vitranu

Q: What is Vitranu's official website?

Vitranu's official website is www.vitranu.com

Q: What is Vitranu's Revenue?

Vitranu's revenue is <$5 Million

Q: What industry does Vitranu belong to?

Vitranu is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What is Vitranu competition?

Vitranu top competitors include: Zy Therapeutics , Cavatar , Intratus , ConjuChem

Q: What technology does Vitranu use?

Some of the popular technologies that Vitranu uses are: Google AdSense, Squarespace Online Stores, YouTube, Squarespace

Q: Who is the CTO of Vitranu?

Vitranu's CTO is Katelyn Swindle-Reilly

Q: What does Vitranu do?

Vitranu, Inc. specializes in innovative ophthalmic drug delivery solutions, particularly through its patented Tunable Extended-Release Capsule (TERC) technology. This technology aims to significantly reduce the frequency of eye injections for patients suffering from wet Age-Related Macular Degeneration (wAMD), addressing a critical unmet need in th... e treatment of this condition. By enabling sustained delivery of therapeutics, Vitranu's TERC can potentially decrease the number of injections to two per year or fewer. The company is currently seeking seed funding to further develop its technology and expand its impact on patient care. Read More

Q: Is Vitranu a public company?

Vitranu is private company therefore does not currently have an official ticker symbol

Manufacturing · Ohio, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

7720 Rivers Edge Dr Ste 101, Columbus, O...

Website

www.vitranu.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

About Vitranu

Vitranu, Inc. specializes in innovative ophthalmic drug delivery solutions, particularly through its patented Tunable Extended-Release Capsule (TERC) technology. This technology aims to significantly reduce the frequency of eye injections for patients suffering from wet Age-Related Macular Degeneration (wAMD), addressing a critical unmet need in the treatment of this condition. By enabling sustained delivery of therapeutics, Vitranu's TERC can potentially decrease the number of injections to two per year or fewer. The company is currently seeking seed funding to further develop its technology and expand its impact on patient care.Explore more

Is this data correct?

View contact profiles from Vitranu

SIC Code 28,283NAICS Code 32,325Show more

Vitranu Org Chart

Phone

Katelyn Swindle-Rei...

Chief Technology Officer

Phone

Chief Medical Officer

Phone

Get the full picture

Compare Similar Companies to Vitranu

Compare insights from companies similar to Vitranu, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.